Inhibition of STAT3 and PI3K signaling promotes apoptosis in PEL cells and dual inhibition of PI3K and mTOR kinases inhibits PEL cell proliferation, illustrating STAT3, PI3K and mTOR signaling as potential targets for the treatment of PEL [319]. Here, MTOR is linked to primary effusion lymphoma.